메뉴 건너뛰기




Volumn 11, Issue 1, 2013, Pages

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

Author keywords

Bevacizumab; Cyclophosphamide; HOCl; Immunotherapy; Recurrent ovarian cancer; Tumor vaccine

Indexed keywords

BEVACIZUMAB; CYCLOPHOSPHAMIDE; DENDRITIC CELL VACCINE;

EID: 84879045776     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-149     Document Type: Note
Times cited : (62)

References (161)
  • 1
    • 0035683821 scopus 로고    scopus 로고
    • Cancer vaccines targeting the HER2/neu oncogenic protein
    • Disis ML, Schiffman K. Cancer vaccines targeting the HER2/neu oncogenic protein. Semin Oncol 2001, 28:12-20.
    • (2001) Semin Oncol , vol.28 , pp. 12-20
    • Disis, M.L.1    Schiffman, K.2
  • 3
    • 0034471993 scopus 로고    scopus 로고
    • Clinical trials of HER-2/neu-specific vaccines
    • discussion 92-100
    • Murray JL, Przepiorka D, Ioannides CG. Clinical trials of HER-2/neu-specific vaccines. Semin Oncol 2000, 27:71-75. discussion 92-100.
    • (2000) Semin Oncol , vol.27 , pp. 71-75
    • Murray, J.L.1    Przepiorka, D.2    Ioannides, C.G.3
  • 4
    • 1942469352 scopus 로고    scopus 로고
    • Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis
    • 10.1016/S0002-9440(10)63708-X, 1615664, 15111296
    • Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004, 164:1511-1518. 10.1016/S0002-9440(10)63708-X, 1615664, 15111296.
    • (2004) Am J Pathol , vol.164 , pp. 1511-1518
    • Shih Ie, M.1    Kurman, R.J.2
  • 6
    • 2642673605 scopus 로고    scopus 로고
    • A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
    • 10.1084/jem.187.8.1349, 2212223, 9547346
    • Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998, 187:1349-1354. 10.1084/jem.187.8.1349, 2212223, 9547346.
    • (1998) J Exp Med , vol.187 , pp. 1349-1354
    • Stockert, E.1    Jager, E.2    Chen, Y.T.3    Scanlan, M.J.4    Gout, I.5    Karbach, J.6    Arand, M.7    Knuth, A.8    Old, L.J.9
  • 8
    • 0028262113 scopus 로고
    • Telomerase activity in human ovarian carcinoma
    • 10.1073/pnas.91.8.2900, 43481, 8159676
    • Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A 1994, 91:2900-2904. 10.1073/pnas.91.8.2900, 43481, 8159676.
    • (1994) Proc Natl Acad Sci U S A , vol.91 , pp. 2900-2904
    • Counter, C.M.1    Hirte, H.W.2    Bacchetti, S.3    Harley, C.B.4
  • 9
    • 0033151591 scopus 로고    scopus 로고
    • The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
    • 10.1016/S1074-7613(00)80066-7, 10403642
    • Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999, 10:673-679. 10.1016/S1074-7613(00)80066-7, 10403642.
    • (1999) Immunity , vol.10 , pp. 673-679
    • Vonderheide, R.H.1    Hahn, W.C.2    Schultze, J.L.3    Nadler, L.M.4
  • 11
    • 0036105153 scopus 로고    scopus 로고
    • Thor SP: Survivin-a universal tumor antigen
    • Andersen MH. thor SP: Survivin-a universal tumor antigen. Histol Histopathol 2002, 17:669-675.
    • (2002) Histol Histopathol , vol.17 , pp. 669-675
    • Andersen, M.H.1
  • 13
    • 0032429418 scopus 로고    scopus 로고
    • Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex
    • 10.1016/S0161-5890(98)00100-X, 10395201
    • Babcock B, Anderson BW, Papayannopoulos I, Castilleja A, Murray JL, Stifani S, Kudelka AP, Wharton JT, Ioannides CG. Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex. Mol Immunol 1998, 35:1121-1133. 10.1016/S0161-5890(98)00100-X, 10395201.
    • (1998) Mol Immunol , vol.35 , pp. 1121-1133
    • Babcock, B.1    Anderson, B.W.2    Papayannopoulos, I.3    Castilleja, A.4    Murray, J.L.5    Stifani, S.6    Kudelka, A.P.7    Wharton, J.T.8    Ioannides, C.G.9
  • 14
    • 0031672721 scopus 로고    scopus 로고
    • Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides
    • 10.1007/BF02303486, 9869522
    • Peoples GE, Anderson BW, Fisk B, Kudelka AP, Wharton JT, Ioannides CG. Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides. Ann Surg Oncol 1998, 5:743-750. 10.1007/BF02303486, 9869522.
    • (1998) Ann Surg Oncol , vol.5 , pp. 743-750
    • Peoples, G.E.1    Anderson, B.W.2    Fisk, B.3    Kudelka, A.P.4    Wharton, J.T.5    Ioannides, C.G.6
  • 15
    • 2942661595 scopus 로고    scopus 로고
    • Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1
    • 10.1016/j.clim.2004.04.002, 15207781
    • Luby TM, Cole G, Baker L, Kornher JS, Ramstedt U, Hedley ML. Repeated immunization with plasmid DNA formulated in poly(lactide-co-glycolide) microparticles is well tolerated and stimulates durable T cell responses to the tumor-associated antigen cytochrome P450 1B1. Clin Immunol 2004, 112:45-53. 10.1016/j.clim.2004.04.002, 15207781.
    • (2004) Clin Immunol , vol.112 , pp. 45-53
    • Luby, T.M.1    Cole, G.2    Baker, L.3    Kornher, J.S.4    Ramstedt, U.5    Hedley, M.L.6
  • 17
    • 0030796206 scopus 로고    scopus 로고
    • Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationship with histopathology and prognosis
    • 10.1016/S0046-8177(97)90012-5, 9269833
    • Ghazizadeh M, Ogawa H, Sasaki Y, Araki T, Aihara K. Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationship with histopathology and prognosis. Hum Pathol 1997, 28:960-966. 10.1016/S0046-8177(97)90012-5, 9269833.
    • (1997) Hum Pathol , vol.28 , pp. 960-966
    • Ghazizadeh, M.1    Ogawa, H.2    Sasaki, Y.3    Araki, T.4    Aihara, K.5
  • 18
    • 0033935785 scopus 로고    scopus 로고
    • Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine
    • 10.1038/sj.bmt.1702430, 10871727
    • Holmberg LA, Oparin DV, Gooley T, Lilleby K, Bensinger W, Reddish MA, MacLean GD, Longenecker BM, Sandmaier BM. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine. Bone Marrow Transplant 2000, 25:1233-1241. 10.1038/sj.bmt.1702430, 10871727.
    • (2000) Bone Marrow Transplant , vol.25 , pp. 1233-1241
    • Holmberg, L.A.1    Oparin, D.V.2    Gooley, T.3    Lilleby, K.4    Bensinger, W.5    Reddish, M.A.6    MacLean, G.D.7    Longenecker, B.M.8    Sandmaier, B.M.9
  • 19
    • 0346364653 scopus 로고    scopus 로고
    • Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer
    • Miles D, Papazisis K. Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer. Clin Breast Cancer 2003, 3(Suppl 4):S134-S138.
    • (2003) Clin Breast Cancer , vol.3 , Issue.SUPPL. 4
    • Miles, D.1    Papazisis, K.2
  • 21
    • 67649624673 scopus 로고    scopus 로고
    • Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer
    • 10.1002/cncr.24317, 2754811, 19472394
    • Adams SF, Levine DA, Cadungog MG, Hammond R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA, Coukos G. Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer. Cancer 2009, 115:2891-2902. 10.1002/cncr.24317, 2754811, 19472394.
    • (2009) Cancer , vol.115 , pp. 2891-2902
    • Adams, S.F.1    Levine, D.A.2    Cadungog, M.G.3    Hammond, R.4    Facciabene, A.5    Olvera, N.6    Rubin, S.C.7    Boyd, J.8    Gimotty, P.A.9    Coukos, G.10
  • 25
    • 42749092358 scopus 로고    scopus 로고
    • Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer
    • Epub 2008 Mar 7, 10.1016/j.ygyno.2008.01.010, 18314181
    • Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM, Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol 2008, 109(2):215-9. Epub 2008 Mar 7, 10.1016/j.ygyno.2008.01.010, 18314181.
    • (2008) Gynecol Oncol , vol.109 , Issue.2 , pp. 215-219
    • Shah, C.A.1    Allison, K.H.2    Garcia, R.L.3    Gray, H.J.4    Goff, B.A.5    Swisher, E.M.6    Shah, C.A.7    Allison, K.H.8    Garcia, R.L.9    Gray, H.J.10    Goff, B.A.11    Swisher, E.M.12
  • 26
    • 38649133581 scopus 로고    scopus 로고
    • Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
    • 10.1016/j.ygyno.2007.10.016, 18037158
    • Tomsova M, Melichar B, Sedlakova I, Steiner I. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol 2008, 108:415-420. 10.1016/j.ygyno.2007.10.016, 18037158.
    • (2008) Gynecol Oncol , vol.108 , pp. 415-420
    • Tomsova, M.1    Melichar, B.2    Sedlakova, I.3    Steiner, I.4
  • 27
    • 70350657101 scopus 로고    scopus 로고
    • Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
    • 10.1038/sj.bjc.6605274, 2778517, 19861998
    • Stumpf M, Hasenburg A, Riener MO, Jutting U, Wang C, Shen Y, Orlowska-Volk M, Fisch P, Wang Z, Gitsch G, Werner M, Lassmann S. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. Br J Cancer 2009, 101:1513-1521. 10.1038/sj.bjc.6605274, 2778517, 19861998.
    • (2009) Br J Cancer , vol.101 , pp. 1513-1521
    • Stumpf, M.1    Hasenburg, A.2    Riener, M.O.3    Jutting, U.4    Wang, C.5    Shen, Y.6    Orlowska-Volk, M.7    Fisch, P.8    Wang, Z.9    Gitsch, G.10    Werner, M.11    Lassmann, S.12
  • 28
    • 68149141666 scopus 로고    scopus 로고
    • Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors
    • 10.1371/journal.pone.0006412, 2712762, 19641607
    • Milne K, Kobel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, Watson PH, Nelson BH. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS One 2009, 4:e6412. 10.1371/journal.pone.0006412, 2712762, 19641607.
    • (2009) PLoS One , vol.4
    • Milne, K.1    Kobel, M.2    Kalloger, S.E.3    Barnes, R.O.4    Gao, D.5    Gilks, C.B.6    Watson, P.H.7    Nelson, B.H.8
  • 30
    • 0032793847 scopus 로고    scopus 로고
    • Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans
    • 10.1006/gyno.1999.5430, 10385556
    • Hayashi K, Yonamine K, Masuko-Hongo K, Iida T, Yamamoto K, Nishioka K, Kato T. Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans. Gynecol Oncol 1999, 74:86-92. 10.1006/gyno.1999.5430, 10385556.
    • (1999) Gynecol Oncol , vol.74 , pp. 86-92
    • Hayashi, K.1    Yonamine, K.2    Masuko-Hongo, K.3    Iida, T.4    Yamamoto, K.5    Nishioka, K.6    Kato, T.7
  • 32
    • 0029053749 scopus 로고
    • Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
    • 10.1084/jem.181.6.2109, 2192068, 7539040
    • Fisk B, Blevins TL, Wharton JT, Ioannides CG. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J Exp Med 1995, 181:2109-2117. 10.1084/jem.181.6.2109, 2192068, 7539040.
    • (1995) J Exp Med , vol.181 , pp. 2109-2117
    • Fisk, B.1    Blevins, T.L.2    Wharton, J.T.3    Ioannides, C.G.4
  • 33
    • 0027787511 scopus 로고
    • Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells
    • Kooi S, Freedman RS, Rodriguez-Villanueva J, Platsoucas CD. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells. Lymphokine Cytokine Res 1993, 12:429-437.
    • (1993) Lymphokine Cytokine Res , vol.12 , pp. 429-437
    • Kooi, S.1    Freedman, R.S.2    Rodriguez-Villanueva, J.3    Platsoucas, C.D.4
  • 34
    • 0028857587 scopus 로고
    • Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide
    • 10.1073/pnas.92.2.432, 42754, 7831305
    • Peoples GE, Goedegebuure PS, Smith R, Linehan DC, Yoshino I, Eberlein TJ. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Proc Natl Acad Sci USA 1995, 92:432-436. 10.1073/pnas.92.2.432, 42754, 7831305.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 432-436
    • Peoples, G.E.1    Goedegebuure, P.S.2    Smith, R.3    Linehan, D.C.4    Yoshino, I.5    Eberlein, T.J.6
  • 36
    • 0034734986 scopus 로고    scopus 로고
    • Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells
    • 10.1016/S0029-7844(00)00916-9, 10960637
    • Santin AD, Bellone S, Ravaggi A, Pecorelli S, Cannon MJ, Parham GP. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Obstet Gynecol 2000, 96:422-430. 10.1016/S0029-7844(00)00916-9, 10960637.
    • (2000) Obstet Gynecol , vol.96 , pp. 422-430
    • Santin, A.D.1    Bellone, S.2    Ravaggi, A.3    Pecorelli, S.4    Cannon, M.J.5    Parham, G.P.6
  • 43
    • 0027894188 scopus 로고
    • Tumor cell vaccination for gynecological tumors
    • 10.1089/hyb.1993.12.543, 7905460
    • Mobus V, Horn S, Stock M, Schirrmacher V. Tumor cell vaccination for gynecological tumors. Hybridoma 1993, 12:543-547. 10.1089/hyb.1993.12.543, 7905460.
    • (1993) Hybridoma , vol.12 , pp. 543-547
    • Mobus, V.1    Horn, S.2    Stock, M.3    Schirrmacher, V.4
  • 44
    • 0036181959 scopus 로고    scopus 로고
    • Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial
    • 10.1007/s00262-001-0255-1, 11845259
    • Hernando JJ, Park TW, Kubler K, Offergeld R, Schlebusch H, Bauknecht T. Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial. Cancer Immunol Immunother 2002, 51:45-52. 10.1007/s00262-001-0255-1, 11845259.
    • (2002) Cancer Immunol Immunother , vol.51 , pp. 45-52
    • Hernando, J.J.1    Park, T.W.2    Kubler, K.3    Offergeld, R.4    Schlebusch, H.5    Bauknecht, T.6
  • 45
    • 40749136616 scopus 로고    scopus 로고
    • Immunotherapy opportunities in ovarian cancer
    • 10.1586/14737140.8.2.243, 18279065
    • Chu CS, Kim SH, June CH, Coukos G. Immunotherapy opportunities in ovarian cancer. Expert Rev Anticancer Ther 2008, 8:243-257. 10.1586/14737140.8.2.243, 18279065.
    • (2008) Expert Rev Anticancer Ther , vol.8 , pp. 243-257
    • Chu, C.S.1    Kim, S.H.2    June, C.H.3    Coukos, G.4
  • 50
    • 77953610577 scopus 로고    scopus 로고
    • Whole tumor antigen vaccines
    • 10.1016/j.smim.2010.02.004, 3119500, 20356763
    • Chiang CL, Benencia F, Coukos G. Whole tumor antigen vaccines. Semin Immunol 2010, 22:132-143. 10.1016/j.smim.2010.02.004, 3119500, 20356763.
    • (2010) Semin Immunol , vol.22 , pp. 132-143
    • Chiang, C.L.1    Benencia, F.2    Coukos, G.3
  • 51
    • 17744418516 scopus 로고    scopus 로고
    • CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity
    • 10.1006/smim.1998.0147, 9826577
    • Toes RE, Schoenberger SP, van der Voort EI, Offringa R, Melief CJ. CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin Immunol 1998, 10:443-448. 10.1006/smim.1998.0147, 9826577.
    • (1998) Semin Immunol , vol.10 , pp. 443-448
    • Toes, R.E.1    Schoenberger, S.P.2    van der Voort, E.I.3    Offringa, R.4    Melief, C.J.5
  • 52
    • 0032146748 scopus 로고    scopus 로고
    • Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells
    • 10.1016/S0952-7915(98)80119-2, 9722921
    • Zajac AJ, Murali-Krishna K, Blattman JN, Ahmed R. Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells. Curr Opin Immunol 1998, 10:444-449. 10.1016/S0952-7915(98)80119-2, 9722921.
    • (1998) Curr Opin Immunol , vol.10 , pp. 444-449
    • Zajac, A.J.1    Murali-Krishna, K.2    Blattman, J.N.3    Ahmed, R.4
  • 53
    • 49149130306 scopus 로고    scopus 로고
    • Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells
    • Wong SB, Bos R, Sherman LA. Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells. J Immunol 2008, 180:3122-3131.
    • (2008) J Immunol , vol.180 , pp. 3122-3131
    • Wong, S.B.1    Bos, R.2    Sherman, L.A.3
  • 54
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • 10.1038/nature10166, 3163504, 21720365, Cancer Genome Atlas Research N
    • Cancer Genome Atlas Research N Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. 10.1038/nature10166, 3163504, 21720365, Cancer Genome Atlas Research N.
    • (2011) Nature , vol.474 , pp. 609-615
  • 55
    • 55749115774 scopus 로고    scopus 로고
    • Antigens for cancer immunotherapy
    • 10.1016/j.smim.2008.09.006, 18951039
    • Neller MA, Lopez JA, Schmidt CW. Antigens for cancer immunotherapy. Semin Immunol 2008, 20:286-295. 10.1016/j.smim.2008.09.006, 18951039.
    • (2008) Semin Immunol , vol.20 , pp. 286-295
    • Neller, M.A.1    Lopez, J.A.2    Schmidt, C.W.3
  • 57
    • 0032102258 scopus 로고    scopus 로고
    • Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes
    • 10.1172/JCI1518, 508847, 9616229
    • Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC, Whiteside TL. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest 1998, 101:2579-2588. 10.1172/JCI1518, 508847, 9616229.
    • (1998) J Clin Invest , vol.101 , pp. 2579-2588
    • Rabinowich, H.1    Reichert, T.E.2    Kashii, Y.3    Gastman, B.R.4    Bell, M.C.5    Whiteside, T.L.6
  • 58
    • 0037126310 scopus 로고    scopus 로고
    • Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
    • 10.1038/nature01112, 12384702
    • Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002, 419:734-738. 10.1038/nature01112, 12384702.
    • (2002) Nature , vol.419 , pp. 734-738
    • Groh, V.1    Wu, J.2    Yee, C.3    Spies, T.4
  • 59
  • 61
    • 0141889560 scopus 로고    scopus 로고
    • Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm
    • 10.2174/1566523034578401, 12653405
    • Coukos G, Courreges MC, Benencia F. Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm. Curr Gene Ther 2003, 3:113-125. 10.2174/1566523034578401, 12653405.
    • (2003) Curr Gene Ther , vol.3 , pp. 113-125
    • Coukos, G.1    Courreges, M.C.2    Benencia, F.3
  • 62
    • 81055127506 scopus 로고    scopus 로고
    • Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
    • 10.1186/1479-5876-9-198, 3283529, 22082029
    • Chiang CL, Maier DA, Kandalaft LE, Brennan AL, Lanitis E, Ye Q, Levine BL, Czerniecki BJ, Powell DJ, Coukos G. Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate. J Transl Med 2011, 9:198. 10.1186/1479-5876-9-198, 3283529, 22082029.
    • (2011) J Transl Med , vol.9 , pp. 198
    • Chiang, C.L.1    Maier, D.A.2    Kandalaft, L.E.3    Brennan, A.L.4    Lanitis, E.5    Ye, Q.6    Levine, B.L.7    Czerniecki, B.J.8    Powell, D.J.9    Coukos, G.10
  • 63
    • 0037072758 scopus 로고    scopus 로고
    • Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions
    • 10.1074/jbc.M202890200, 12114509
    • Callahan MK, Chaillot D, Jacquin C, Clark PR, Menoret A. Differential acquisition of antigenic peptides by Hsp70 and Hsc70 under oxidative conditions. J Biol Chem 2002, 277:33604-33609. 10.1074/jbc.M202890200, 12114509.
    • (2002) J Biol Chem , vol.277 , pp. 33604-33609
    • Callahan, M.K.1    Chaillot, D.2    Jacquin, C.3    Clark, P.R.4    Menoret, A.5
  • 64
    • 0031732062 scopus 로고    scopus 로고
    • Immunological adjuvance of metabolic origin: oxidative stress, postulated impaired function of thiol proteases and immunogenicity
    • 10.1046/j.1365-3083.1998.00443.x, 9822254
    • Stark JM. Immunological adjuvance of metabolic origin: oxidative stress, postulated impaired function of thiol proteases and immunogenicity. Scand J Immunol 1998, 48:475-479. 10.1046/j.1365-3083.1998.00443.x, 9822254.
    • (1998) Scand J Immunol , vol.48 , pp. 475-479
    • Stark, J.M.1
  • 65
    • 0036911138 scopus 로고    scopus 로고
    • Hydrogen peroxide as second messenger in lymphocyte activation
    • 10.1038/ni1202-1129, 12447370
    • Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002, 3:1129-1134. 10.1038/ni1202-1129, 12447370.
    • (2002) Nat Immunol , vol.3 , pp. 1129-1134
    • Reth, M.1
  • 66
    • 0344286517 scopus 로고    scopus 로고
    • The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells
    • 10.1016/S0891-5849(98)00133-6, 9890636
    • Tatla S, Woodhead V, Foreman JC, Chain BM. The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells. Free Radic Biol Med 1999, 26:14-24. 10.1016/S0891-5849(98)00133-6, 9890636.
    • (1999) Free Radic Biol Med , vol.26 , pp. 14-24
    • Tatla, S.1    Woodhead, V.2    Foreman, J.C.3    Chain, B.M.4
  • 67
    • 51049094007 scopus 로고    scopus 로고
    • Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor
    • 10.1158/1078-0432.CCR-07-4899, 18676764
    • Chiang CL, Ledermann JA, Aitkens E, Benjamin E, Katz DR, Chain BM. Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor. Clin Cancer Res 2008, 14:4898-4907. 10.1158/1078-0432.CCR-07-4899, 18676764.
    • (2008) Clin Cancer Res , vol.14 , pp. 4898-4907
    • Chiang, C.L.1    Ledermann, J.A.2    Aitkens, E.3    Benjamin, E.4    Katz, D.R.5    Chain, B.M.6
  • 68
    • 33746894710 scopus 로고    scopus 로고
    • Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells
    • 10.1007/s00262-006-0127-9, 16463039
    • Chiang CL, Ledermann JA, Rad AN, Katz DR, Chain BM. Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells. Cancer Immunol Immunother 2006, 55:1384-1395. 10.1007/s00262-006-0127-9, 16463039.
    • (2006) Cancer Immunol Immunother , vol.55 , pp. 1384-1395
    • Chiang, C.L.1    Ledermann, J.A.2    Rad, A.N.3    Katz, D.R.4    Chain, B.M.5
  • 69
    • 0030854261 scopus 로고    scopus 로고
    • Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
    • 10.1172/JCI119176, 507815, 9022075
    • Anderson MM, Hazen SL, Hsu FF, Heinecke JW. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest 1997, 99:424-432. 10.1172/JCI119176, 507815, 9022075.
    • (1997) J Clin Invest , vol.99 , pp. 424-432
    • Anderson, M.M.1    Hazen, S.L.2    Hsu, F.F.3    Heinecke, J.W.4
  • 70
    • 0032694683 scopus 로고    scopus 로고
    • The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
    • 10.1172/JCI3042, 408396, 10393704
    • Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 1999, 104:103-113. 10.1172/JCI3042, 408396, 10393704.
    • (1999) J Clin Invest , vol.104 , pp. 103-113
    • Anderson, M.M.1    Requena, J.R.2    Crowley, J.R.3    Thorpe, S.R.4    Heinecke, J.W.5
  • 71
    • 10144255096 scopus 로고    scopus 로고
    • Human neutrophils employ chlorine gas as an oxidant during phagocytosis
    • 10.1172/JCI118914, 507553, 8823292
    • Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 1996, 98:1283-1289. 10.1172/JCI118914, 507553, 8823292.
    • (1996) J Clin Invest , vol.98 , pp. 1283-1289
    • Hazen, S.L.1    Hsu, F.F.2    Mueller, D.M.3    Crowley, J.R.4    Heinecke, J.W.5
  • 72
    • 0031762701 scopus 로고    scopus 로고
    • Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells
    • 10.1046/j.1365-2567.1998.00618.x, 1364395, 9824492
    • Carrasco-Marin E, Paz-Miguel JE, Lopez-Mato P, Alvarez-Dominguez C, Leyva-Cobian F. Oxidation of defined antigens allows protein unfolding and increases both proteolytic processing and exposes peptide epitopes which are recognized by specific T cells. Immunology 1998, 95:314-321. 10.1046/j.1365-2567.1998.00618.x, 1364395, 9824492.
    • (1998) Immunology , vol.95 , pp. 314-321
    • Carrasco-Marin, E.1    Paz-Miguel, J.E.2    Lopez-Mato, P.3    Alvarez-Dominguez, C.4    Leyva-Cobian, F.5
  • 73
    • 0035993485 scopus 로고    scopus 로고
    • LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis
    • 10.1016/S0163-7258(02)00236-X, 12163130
    • Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002, 95:89-100. 10.1016/S0163-7258(02)00236-X, 12163130.
    • (2002) Pharmacol Ther , vol.95 , pp. 89-100
    • Chen, M.1    Masaki, T.2    Sawamura, T.3
  • 75
    • 0032482958 scopus 로고    scopus 로고
    • Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells
    • 10.1073/pnas.95.16.9535, 21373, 9689115
    • Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, Kita T, Masaki T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci USA 1998, 95:9535-9540. 10.1073/pnas.95.16.9535, 21373, 9689115.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 9535-9540
    • Oka, K.1    Sawamura, T.2    Kikuta, K.3    Itokawa, S.4    Kume, N.5    Kita, T.6    Masaki, T.7
  • 76
    • 77956924939 scopus 로고    scopus 로고
    • Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway
    • 10.4049/jimmunol.0903214, 20631313
    • Xie J, Zhu H, Guo L, Ruan Y, Wang L, Sun L, Zhou L, Wu W, Yun X, Shen A, Gu J. Lectin-like oxidized low-density lipoprotein receptor-1 delivers heat shock protein 60-fused antigen into the MHC class I presentation pathway. J Immunol 2010, 185:2306-2313. 10.4049/jimmunol.0903214, 20631313.
    • (2010) J Immunol , vol.185 , pp. 2306-2313
    • Xie, J.1    Zhu, H.2    Guo, L.3    Ruan, Y.4    Wang, L.5    Sun, L.6    Zhou, L.7    Wu, W.8    Yun, X.9    Shen, A.10    Gu, J.11
  • 77
    • 0031941423 scopus 로고    scopus 로고
    • Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
    • 10.1038/nm0398-328, 9500607
    • Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998, 4:328-332. 10.1038/nm0398-328, 9500607.
    • (1998) Nat Med , vol.4 , pp. 328-332
    • Nestle, F.O.1    Alijagic, S.2    Gilliet, M.3    Sun, Y.4    Grabbe, S.5    Dummer, R.6    Burg, G.7    Schadendorf, D.8
  • 78
    • 0041530710 scopus 로고    scopus 로고
    • Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells
    • 10.1182/blood-2002-08-2455, 12714511
    • Maier T, Tun-Kyi A, Tassis A, Jungius KP, Burg G, Dummer R, Nestle FO. Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood 2003, 102:2338-2344. 10.1182/blood-2002-08-2455, 12714511.
    • (2003) Blood , vol.102 , pp. 2338-2344
    • Maier, T.1    Tun-Kyi, A.2    Tassis, A.3    Jungius, K.P.4    Burg, G.5    Dummer, R.6    Nestle, F.O.7
  • 81
    • 0344076299 scopus 로고    scopus 로고
    • Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
    • 10.1016/S0022-1759(98)00208-7, 10037230
    • Thurner B, Roder C, Dieckmann D, Heuer M, Kruse M, Glaser A, Keikavoussi P, Kampgen E, Bender A, Schuler G. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999, 223:1-15. 10.1016/S0022-1759(98)00208-7, 10037230.
    • (1999) J Immunol Methods , vol.223 , pp. 1-15
    • Thurner, B.1    Roder, C.2    Dieckmann, D.3    Heuer, M.4    Kruse, M.5    Glaser, A.6    Keikavoussi, P.7    Kampgen, E.8    Bender, A.9    Schuler, G.10
  • 82
    • 17444428074 scopus 로고    scopus 로고
    • Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells
    • 10.1016/j.jim.2005.01.005, 15847797
    • Berger TG, Strasser E, Smith R, Carste C, Schuler-Thurner B, Kaempgen E, Schuler G. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells. J Immunol Methods 2005, 298:61-72. 10.1016/j.jim.2005.01.005, 15847797.
    • (2005) J Immunol Methods , vol.298 , pp. 61-72
    • Berger, T.G.1    Strasser, E.2    Smith, R.3    Carste, C.4    Schuler-Thurner, B.5    Kaempgen, E.6    Schuler, G.7
  • 83
    • 0037107533 scopus 로고    scopus 로고
    • Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories
    • 10.1016/S0022-1759(02)00189-8, 12215381
    • Berger TG, Feuerstein B, Strasser E, Hirsch U, Schreiner D, Schuler G, Schuler-Thurner B. Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J Immunol Methods 2002, 268:131-140. 10.1016/S0022-1759(02)00189-8, 12215381.
    • (2002) J Immunol Methods , vol.268 , pp. 131-140
    • Berger, T.G.1    Feuerstein, B.2    Strasser, E.3    Hirsch, U.4    Schreiner, D.5    Schuler, G.6    Schuler-Thurner, B.7
  • 85
    • 1642456671 scopus 로고    scopus 로고
    • Dendritic cells: immunobiology and cancer immunotherapy
    • 10.1016/S1074-7613(03)00352-2, 14738761
    • Ardavin C, Amigorena S, Reis E, Sousa C. Dendritic cells: immunobiology and cancer immunotherapy. Immunity 2004, 20:17-23. 10.1016/S1074-7613(03)00352-2, 14738761.
    • (2004) Immunity , vol.20 , pp. 17-23
    • Ardavin, C.1    Amigorena, S.2    Reis, E.3    Sousa, C.4
  • 87
    • 83355170576 scopus 로고    scopus 로고
    • Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses
    • 10.1371/journal.pone.0028732, 3237492, 22194898
    • Chiang CL, Hagemann AR, Leskowitz R, Mick R, Garrabrant T, Czerniecki BJ, Kandalaft LE, Powell DJ, Coukos G. Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. PLoS One 2011, 6:e28732. 10.1371/journal.pone.0028732, 3237492, 22194898.
    • (2011) PLoS One , vol.6
    • Chiang, C.L.1    Hagemann, A.R.2    Leskowitz, R.3    Mick, R.4    Garrabrant, T.5    Czerniecki, B.J.6    Kandalaft, L.E.7    Powell, D.J.8    Coukos, G.9
  • 88
    • 7644237187 scopus 로고    scopus 로고
    • Tumor-host immune interactions and dendritic cell dysfunction
    • Yang L, Carbone DP. Tumor-host immune interactions and dendritic cell dysfunction. Adv Cancer Res 2004, 92:13-27.
    • (2004) Adv Cancer Res , vol.92 , pp. 13-27
    • Yang, L.1    Carbone, D.P.2
  • 89
    • 0034984740 scopus 로고    scopus 로고
    • VEGF as a mediator of tumor-associated immunodeficiency
    • 10.1385/IR:23:2-3:263, 11444391
    • Ohm JE, Carbone DP. VEGF as a mediator of tumor-associated immunodeficiency. Immunol Res 2001, 23:263-272. 10.1385/IR:23:2-3:263, 11444391.
    • (2001) Immunol Res , vol.23 , pp. 263-272
    • Ohm, J.E.1    Carbone, D.P.2
  • 90
    • 0032400862 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
    • Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998, 92:4150-4166.
    • (1998) Blood , vol.92 , pp. 4150-4166
    • Gabrilovich, D.1    Ishida, T.2    Oyama, T.3    Ran, S.4    Kravtsov, V.5    Nadaf, S.6    Carbone, D.P.7
  • 91
    • 0029842830 scopus 로고    scopus 로고
    • Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
    • 10.1038/nm1096-1096, 8837607
    • Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996, 2:1096-1103. 10.1038/nm1096-1096, 8837607.
    • (1996) Nat Med , vol.2 , pp. 1096-1103
    • Gabrilovich, D.I.1    Chen, H.L.2    Girgis, K.R.3    Cunningham, H.T.4    Meny, G.M.5    Nadaf, S.6    Kavanaugh, D.7    Carbone, D.P.8
  • 92
    • 0031892785 scopus 로고    scopus 로고
    • Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells
    • Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP, Gabrilovich DI. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 1998, 160:1224-1232.
    • (1998) J Immunol , vol.160 , pp. 1224-1232
    • Oyama, T.1    Ran, S.2    Ishida, T.3    Nadaf, S.4    Kerr, L.5    Carbone, D.P.6    Gabrilovich, D.I.7
  • 93
    • 0032211082 scopus 로고    scopus 로고
    • Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors
    • Ishida T, Oyama T, Carbone DP, Gabrilovich DI. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. J Immunol 1998, 161:4842-4851.
    • (1998) J Immunol , vol.161 , pp. 4842-4851
    • Ishida, T.1    Oyama, T.2    Carbone, D.P.3    Gabrilovich, D.I.4
  • 94
    • 2542470851 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines
    • 10.1007/s00262-003-0466-8, 14666382
    • Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y. Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol Immunother 2004, 53:543-550. 10.1007/s00262-003-0466-8, 14666382.
    • (2004) Cancer Immunol Immunother , vol.53 , pp. 543-550
    • Takahashi, A.1    Kono, K.2    Ichihara, F.3    Sugai, H.4    Fujii, H.5    Matsumoto, Y.6
  • 95
    • 0033568001 scopus 로고    scopus 로고
    • Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo
    • Ohm JE, Shurin MR, Esche C, Lotze MT, Carbone DP, Gabrilovich DI. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. J Immunol 1999, 163:3260-3268.
    • (1999) J Immunol , vol.163 , pp. 3260-3268
    • Ohm, J.E.1    Shurin, M.R.2    Esche, C.3    Lotze, M.T.4    Carbone, D.P.5    Gabrilovich, D.I.6
  • 99
    • 0032741283 scopus 로고    scopus 로고
    • Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function
    • Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin Cancer Res 1999, 5:2963-2970.
    • (1999) Clin Cancer Res , vol.5 , pp. 2963-2970
    • Gabrilovich, D.I.1    Ishida, T.2    Nadaf, S.3    Ohm, J.E.4    Carbone, D.P.5
  • 100
    • 14644405056 scopus 로고    scopus 로고
    • Hb KOCHI [beta141(H19)Leu-->Val (g.1404-->C G); 144-->146(HC1-3)Lys-Tyr-His-->0 (g.1413 A-->T)]: a new variant with increased oxygen affinity
    • Miyazaki A, Nakanishi T, Shimizu A, Mizobuchi M, Yamada Y, Imai K. Hb KOCHI [beta141(H19)Leu-->Val (g.1404-->C G); 144-->146(HC1-3)Lys-Tyr-His-->0 (g.1413 A-->T)]: a new variant with increased oxygen affinity. Hemoglobin 2005, 29:1-10.
    • (2005) Hemoglobin , vol.29 , pp. 1-10
    • Miyazaki, A.1    Nakanishi, T.2    Shimizu, A.3    Mizobuchi, M.4    Yamada, Y.5    Imai, K.6
  • 101
    • 0043245914 scopus 로고    scopus 로고
    • Synergy between tumor immunotherapy and antiangiogenic therapy
    • 10.1182/blood-2002-12-3738, 12689940
    • Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E. Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 2003, 102:964-971. 10.1182/blood-2002-12-3738, 12689940.
    • (2003) Blood , vol.102 , pp. 964-971
    • Nair, S.1    Boczkowski, D.2    Moeller, B.3    Dewhirst, M.4    Vieweg, J.5    Gilboa, E.6
  • 102
    • 33845343558 scopus 로고    scopus 로고
    • Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy
    • 10.1158/1078-0432.CCR-06-1558, 17121902
    • Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy. Clin Cancer Res 2006, 12:6808-6816. 10.1158/1078-0432.CCR-06-1558, 17121902.
    • (2006) Clin Cancer Res , vol.12 , pp. 6808-6816
    • Li, B.1    Lalani, A.S.2    Harding, T.C.3    Luan, B.4    Koprivnikar, K.5    Huan Tu, G.6    Prell, R.7    VanRoey, M.J.8    Simmons, A.D.9    Jooss, K.10
  • 103
    • 33646164362 scopus 로고    scopus 로고
    • Transforming growth factor-beta regulation of immune responses
    • 10.1146/annurev.immunol.24.021605.090737, 16551245
    • Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006, 24:99-146. 10.1146/annurev.immunol.24.021605.090737, 16551245.
    • (2006) Annu Rev Immunol , vol.24 , pp. 99-146
    • Li, M.O.1    Wan, Y.Y.2    Sanjabi, S.3    Robertson, A.K.4    Flavell, R.A.5
  • 104
    • 33745304967 scopus 로고    scopus 로고
    • Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy
    • 10.1002/cncr.21956, 16736512
    • Rini BI, Weinberg V, Fong L, Conry S, Hershberg RM, Small EJ. Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy. Cancer 2006, 107:67-74. 10.1002/cncr.21956, 16736512.
    • (2006) Cancer , vol.107 , pp. 67-74
    • Rini, B.I.1    Weinberg, V.2    Fong, L.3    Conry, S.4    Hershberg, R.M.5    Small, E.J.6
  • 106
    • 68049099399 scopus 로고    scopus 로고
    • Endothelin B receptor, a new target in cancer immune therapy
    • 10.1158/1078-0432.CCR-08-0543, 2896814, 19567593
    • Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G. Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 2009, 15:4521-4528. 10.1158/1078-0432.CCR-08-0543, 2896814, 19567593.
    • (2009) Clin Cancer Res , vol.15 , pp. 4521-4528
    • Kandalaft, L.E.1    Facciabene, A.2    Buckanovich, R.J.3    Coukos, G.4
  • 108
    • 11144308977 scopus 로고    scopus 로고
    • Endothelin-1 Stimulates Cyclooxygenase-2 Expression in Ovarian Cancer Cells Through Multiple Signaling Pathways: Evidence for Involvement of Transactivation of the Epidermal Growth Factor Receptor
    • 10.1097/01.fjc.0000166255.12229.0d, 15838264
    • Spinella F, Rosano L, Elia G, Di Castro V, Natali PG, Bagnato A. Endothelin-1 Stimulates Cyclooxygenase-2 Expression in Ovarian Cancer Cells Through Multiple Signaling Pathways: Evidence for Involvement of Transactivation of the Epidermal Growth Factor Receptor. J Cardiovasc Pharmacol 2004, 44:S140-S143. 10.1097/01.fjc.0000166255.12229.0d, 15838264.
    • (2004) J Cardiovasc Pharmacol , vol.44
    • Spinella, F.1    Rosano, L.2    Elia, G.3    Di Castro, V.4    Natali, P.G.5    Bagnato, A.6
  • 109
    • 33847737677 scopus 로고    scopus 로고
    • Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells
    • 10.1158/0008-5472.CAN-06-2606, 17308114
    • Spinella F, Rosano L, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Cancer Res 2007, 67:1725-1734. 10.1158/0008-5472.CAN-06-2606, 17308114.
    • (2007) Cancer Res , vol.67 , pp. 1725-1734
    • Spinella, F.1    Rosano, L.2    Di Castro, V.3    Decandia, S.4    Nicotra, M.R.5    Natali, P.G.6    Bagnato, A.7
  • 110
    • 0042845963 scopus 로고    scopus 로고
    • Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo
    • 10.1016/S0002-9440(10)63702-9, 1868202, 12875994
    • Rosano L, Spinella F, Di Castro V, Nicotra MR, Albini A, Natali PG, Bagnato A. Endothelin receptor blockade inhibits molecular effectors of Kaposi's sarcoma cell invasion and tumor growth in vivo. Am J Pathol 2003, 163:753-762. 10.1016/S0002-9440(10)63702-9, 1868202, 12875994.
    • (2003) Am J Pathol , vol.163 , pp. 753-762
    • Rosano, L.1    Spinella, F.2    Di Castro, V.3    Nicotra, M.R.4    Albini, A.5    Natali, P.G.6    Bagnato, A.7
  • 111
    • 0037008695 scopus 로고    scopus 로고
    • Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells
    • 10.1074/jbc.M202421200, 12023962
    • Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 2002, 277:27850-27855. 10.1074/jbc.M202421200, 12023962.
    • (2002) J Biol Chem , vol.277 , pp. 27850-27855
    • Spinella, F.1    Rosano, L.2    Di Castro, V.3    Natali, P.G.4    Bagnato, A.5
  • 112
    • 0033724661 scopus 로고    scopus 로고
    • Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo
    • 10.1016/S0002-9440(10)64807-9, 1885730, 11073829
    • Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000, 157:1703-1711. 10.1016/S0002-9440(10)64807-9, 1885730, 11073829.
    • (2000) Am J Pathol , vol.157 , pp. 1703-1711
    • Salani, D.1    Taraboletti, G.2    Rosano, L.3    Di Castro, V.4    Borsotti, P.5    Giavazzi, R.6    Bagnato, A.7
  • 113
    • 0036899148 scopus 로고    scopus 로고
    • Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma
    • 10.1016/S0002-9440(10)64505-1, 1850900, 12466143
    • Zhang L, Yang N, Conejo-Garcia J-R, Mohamed A, Benencia F, Rubin SC, Allman D, Coukos G. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am J Pathol 2002, 161:2295-2309. 10.1016/S0002-9440(10)64505-1, 1850900, 12466143.
    • (2002) Am J Pathol , vol.161 , pp. 2295-2309
    • Zhang, L.1    Yang, N.2    Conejo-Garcia, J.-R.3    Mohamed, A.4    Benencia, F.5    Rubin, S.C.6    Allman, D.7    Coukos, G.8
  • 116
    • 77955406159 scopus 로고    scopus 로고
    • Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer
    • 10.1158/0008-5472.CAN-10-0153, 2912959, 20631075
    • Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA. Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer. Cancer Res 2010, 70:6171-6180. 10.1158/0008-5472.CAN-10-0153, 2912959, 20631075.
    • (2010) Cancer Res , vol.70 , pp. 6171-6180
    • Shrimali, R.K.1    Yu, Z.2    Theoret, M.R.3    Chinnasamy, D.4    Restifo, N.P.5    Rosenberg, S.A.6
  • 117
    • 0023785002 scopus 로고
    • Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide
    • 10.3109/07357908809080657, 3167614
    • Berd D, Mastrangelo MJ. Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide. Cancer Invest 1988, 6:337-349. 10.3109/07357908809080657, 3167614.
    • (1988) Cancer Invest , vol.6 , pp. 337-349
    • Berd, D.1    Mastrangelo, M.J.2
  • 118
    • 0020047427 scopus 로고
    • Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells
    • 10.1084/jem.155.4.1063, 2186638, 6460831
    • North RJ. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 1982, 155:1063-1074. 10.1084/jem.155.4.1063, 2186638, 6460831.
    • (1982) J Exp Med , vol.155 , pp. 1063-1074
    • North, R.J.1
  • 119
    • 0024598609 scopus 로고
    • Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells
    • Awwad M, North RJ. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res 1989, 49:1649-1654.
    • (1989) Cancer Res , vol.49 , pp. 1649-1654
    • Awwad, M.1    North, R.J.2
  • 120
    • 0035328683 scopus 로고    scopus 로고
    • Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
    • Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001, 61:3689-3697.
    • (2001) Cancer Res , vol.61 , pp. 3689-3697
    • Machiels, J.P.1    Reilly, R.T.2    Emens, L.A.3    Ercolini, A.M.4    Lei, R.Y.5    Weintraub, D.6    Okoye, F.I.7    Jaffee, E.M.8
  • 122
    • 70350434889 scopus 로고    scopus 로고
    • Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma
    • 10.1111/j.1752-8062.2008.00070.x, 2847413, 20357913
    • Leao IC, Ganesan P, Armstrong TD, Jaffee EM. Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma. Clin Transl Sci 2008, 1:228-239. 10.1111/j.1752-8062.2008.00070.x, 2847413, 20357913.
    • (2008) Clin Transl Sci , vol.1 , pp. 228-239
    • Leao, I.C.1    Ganesan, P.2    Armstrong, T.D.3    Jaffee, E.M.4
  • 124
    • 0022597114 scopus 로고
    • Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide
    • Berd D, Maguire HC, Mastrangelo MJ. Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 1986, 46:2572-2577.
    • (1986) Cancer Res , vol.46 , pp. 2572-2577
    • Berd, D.1    Maguire, H.C.2    Mastrangelo, M.J.3
  • 126
    • 40949157885 scopus 로고    scopus 로고
    • Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation
    • 10.1158/1078-0432.CCR-07-0371, 2879140, 18316569
    • Laheru D, Lutz E, Burke J, Biedrzycki B, Solt S, Onners B, Tartakovsky I, Nemunaitis J, Le D, Sugar E. Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation. Clin Cancer Res 2008, 14:1455. 10.1158/1078-0432.CCR-07-0371, 2879140, 18316569.
    • (2008) Clin Cancer Res , vol.14 , pp. 1455
    • Laheru, D.1    Lutz, E.2    Burke, J.3    Biedrzycki, B.4    Solt, S.5    Onners, B.6    Tartakovsky, I.7    Nemunaitis, J.8    Le, D.9    Sugar, E.10
  • 127
    • 0037458325 scopus 로고    scopus 로고
    • Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis
    • 10.1006/jtbi.2003.3162, 12623285
    • Hahnfeldt P, Folkman J, Hlatky L. Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. J Theor Biol 2003, 220:545-554. 10.1006/jtbi.2003.3162, 12623285.
    • (2003) J Theor Biol , vol.220 , pp. 545-554
    • Hahnfeldt, P.1    Folkman, J.2    Hlatky, L.3
  • 128
    • 29444432612 scopus 로고    scopus 로고
    • Interim report of a phase II clinical trial of bevacizumab (Bev) and low dose metronomic oral cyclophophamide (mCTX) in recurrent ovarian (OC) and primary peritoneal carcinoma: a California Cancer Consortium Trial
    • Garcia A, Oza A, Hirte H. Interim report of a phase II clinical trial of bevacizumab (Bev) and low dose metronomic oral cyclophophamide (mCTX) in recurrent ovarian (OC) and primary peritoneal carcinoma: a California Cancer Consortium Trial. J Clin Oncol 2005, 23(suppl):5000.
    • (2005) J Clin Oncol , vol.23 , Issue.SUPPL , pp. 5000
    • Garcia, A.1    Oza, A.2    Hirte, H.3
  • 129
    • 35348904080 scopus 로고    scopus 로고
    • Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
    • 10.1016/j.ygyno.2007.07.017, 17706754
    • Chura J, Van Iseghem K, Downs L, Carson LF, Judson P. Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer. Gynecol Oncol 2007, 107:326-330. 10.1016/j.ygyno.2007.07.017, 17706754.
    • (2007) Gynecol Oncol , vol.107 , pp. 326-330
    • Chura, J.1    Van Iseghem, K.2    Downs, L.3    Carson, L.F.4    Judson, P.5
  • 130
    • 0042931259 scopus 로고    scopus 로고
    • Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
    • Xu S, Koski GK, Faries M, Bedrosian I, Mick R, Maeurer M, Cheever MA, Cohen PA, Czerniecki BJ. Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 2003, 171:2251-2261.
    • (2003) J Immunol , vol.171 , pp. 2251-2261
    • Xu, S.1    Koski, G.K.2    Faries, M.3    Bedrosian, I.4    Mick, R.5    Maeurer, M.6    Cheever, M.A.7    Cohen, P.A.8    Czerniecki, B.J.9
  • 133
    • 0026070131 scopus 로고
    • Enhancement of immunogenic properties of ovalbumin as a result of its chlorination
    • 10.1016/0020-711X(91)90280-Z, 1761149
    • Marcinkiewicz J, Chain BM, Olszowska E, Olszowski S, Zgliczynski JM. Enhancement of immunogenic properties of ovalbumin as a result of its chlorination. Int J Biochem 1991, 23:1393-1395. 10.1016/0020-711X(91)90280-Z, 1761149.
    • (1991) Int J Biochem , vol.23 , pp. 1393-1395
    • Marcinkiewicz, J.1    Chain, B.M.2    Olszowska, E.3    Olszowski, S.4    Zgliczynski, J.M.5
  • 134
    • 0026777691 scopus 로고
    • Enhancement of trinitrophenyl-specific humoral response to TNP proteins as the result of carrier chlorination
    • 1421697, 1382040
    • Marcinkiewicz J, Olszowska E, Olszowski S, Zgliczynski JM. Enhancement of trinitrophenyl-specific humoral response to TNP proteins as the result of carrier chlorination. Immunology 1992, 76:385-388. 1421697, 1382040.
    • (1992) Immunology , vol.76 , pp. 385-388
    • Marcinkiewicz, J.1    Olszowska, E.2    Olszowski, S.3    Zgliczynski, J.M.4
  • 135
    • 0033621120 scopus 로고    scopus 로고
    • Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells
    • 10.1073/pnas.96.18.10332, 17888, 10468608
    • Engels FH, Koski GK, Bedrosian I, Xu S, Luger S, Nowell PC, Cohen PA, Czerniecki BJ. Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells. Proc Natl Acad Sci U S A 1999, 96:10332-10337. 10.1073/pnas.96.18.10332, 17888, 10468608.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 10332-10337
    • Engels, F.H.1    Koski, G.K.2    Bedrosian, I.3    Xu, S.4    Luger, S.5    Nowell, P.C.6    Cohen, P.A.7    Czerniecki, B.J.8
  • 136
    • 0034798364 scopus 로고    scopus 로고
    • Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines
    • Czerniecki BJ, Cohen PA, Faries M, Xu S, Roros JG, Bedrosian I. Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines. Crit Rev Immunol 2001, 21:157-178.
    • (2001) Crit Rev Immunol , vol.21 , pp. 157-178
    • Czerniecki, B.J.1    Cohen, P.A.2    Faries, M.3    Xu, S.4    Roros, J.G.5    Bedrosian, I.6
  • 137
    • 41149098249 scopus 로고    scopus 로고
    • Reengineering dendritic cell-based anti-cancer vaccines
    • 10.1111/j.1600-065X.2008.00617.x, 18364007
    • Koski GK, Cohen PA, Roses RE, Xu S, Czerniecki BJ. Reengineering dendritic cell-based anti-cancer vaccines. Immunol Rev 2008, 222:256-276. 10.1111/j.1600-065X.2008.00617.x, 18364007.
    • (2008) Immunol Rev , vol.222 , pp. 256-276
    • Koski, G.K.1    Cohen, P.A.2    Roses, R.E.3    Xu, S.4    Czerniecki, B.J.5
  • 139
    • 78650633859 scopus 로고    scopus 로고
    • Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitro
    • 10.1097/CJI.0b013e3181fb651a, 21150712
    • DeBenedette MA, Calderhead DM, Tcherepanova IY, Nicolette CA, Healey DG. Potency of mature CD40L RNA electroporated dendritic cells correlates with IL-12 secretion by tracking multifunctional CD8(+)/CD28(+) cytotoxic T-cell responses in vitro. J Immunother 2011, 34:45-57. 10.1097/CJI.0b013e3181fb651a, 21150712.
    • (2011) J Immunother , vol.34 , pp. 45-57
    • DeBenedette, M.A.1    Calderhead, D.M.2    Tcherepanova, I.Y.3    Nicolette, C.A.4    Healey, D.G.5
  • 140
    • 76249100089 scopus 로고    scopus 로고
    • Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells
    • 10.4049/jimmunol.0902062, 2922038, 20018619
    • Watchmaker PB, Berk E, Muthuswamy R, Mailliard RB, Urban JA, Kirkwood JM, Kalinski P. Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells. J Immunol 2010, 184:591-597. 10.4049/jimmunol.0902062, 2922038, 20018619.
    • (2010) J Immunol , vol.184 , pp. 591-597
    • Watchmaker, P.B.1    Berk, E.2    Muthuswamy, R.3    Mailliard, R.B.4    Urban, J.A.5    Kirkwood, J.M.6    Kalinski, P.7
  • 142
    • 0035863310 scopus 로고    scopus 로고
    • Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity
    • Lambert LA, Gibson GR, Maloney M, Durell B, Noelle RJ, Barth RJ. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res 2001, 61:641-646.
    • (2001) Cancer Res , vol.61 , pp. 641-646
    • Lambert, L.A.1    Gibson, G.R.2    Maloney, M.3    Durell, B.4    Noelle, R.J.5    Barth, R.J.6
  • 143
    • 0142055970 scopus 로고    scopus 로고
    • Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
    • 10.1200/JCO.2003.04.042, 14551301
    • Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJ. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients. J Clin Oncol 2003, 21:3826-3835. 10.1200/JCO.2003.04.042, 14551301.
    • (2003) J Clin Oncol , vol.21 , pp. 3826-3835
    • Bedrosian, I.1    Mick, R.2    Xu, S.3    Nisenbaum, H.4    Faries, M.5    Zhang, P.6    Cohen, P.A.7    Koski, G.8    Czerniecki, B.J.9
  • 144
    • 0030817612 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
    • 10.1038/bjc.1997.537, 2228134, 9365173
    • Yamamoto S, Konishi I, Mandai M, Kuroda H, Komatsu T, Nanbu K, Sakahara H, Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 1997, 76:1221-1227. 10.1038/bjc.1997.537, 2228134, 9365173.
    • (1997) Br J Cancer , vol.76 , pp. 1221-1227
    • Yamamoto, S.1    Konishi, I.2    Mandai, M.3    Kuroda, H.4    Komatsu, T.5    Nanbu, K.6    Sakahara, H.7    Mori, T.8
  • 145
    • 0031455936 scopus 로고    scopus 로고
    • Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
    • 10.1016/S0304-3835(97)00350-9, 9570355
    • Hartenbach EM, Olson TA, Goswitz JJ, Mohanraj D, Twiggs LB, Carson LF, Ramakrishnan S. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett 1997, 121:169-175. 10.1016/S0304-3835(97)00350-9, 9570355.
    • (1997) Cancer Lett , vol.121 , pp. 169-175
    • Hartenbach, E.M.1    Olson, T.A.2    Goswitz, J.J.3    Mohanraj, D.4    Twiggs, L.B.5    Carson, L.F.6    Ramakrishnan, S.7
  • 146
    • 84861736119 scopus 로고    scopus 로고
    • OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    • 10.1200/JCO.2012.42.0505, 3646321, 22529265
    • Aghajanian C, Blank SV, Goff BA, Judson PL, Teneriello MG, Husain A, Sovak MA, Yi J, Nycum LR. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol 2012, 30:2039-2045. 10.1200/JCO.2012.42.0505, 3646321, 22529265.
    • (2012) J Clin Oncol , vol.30 , pp. 2039-2045
    • Aghajanian, C.1    Blank, S.V.2    Goff, B.A.3    Judson, P.L.4    Teneriello, M.G.5    Husain, A.6    Sovak, M.A.7    Yi, J.8    Nycum, L.R.9
  • 148
    • 79751485813 scopus 로고    scopus 로고
    • Mechanisms of leukocyte transendothelial migration
    • 10.1146/annurev-pathol-011110-130224, 3628537, 21073340
    • Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 2011, 6:323-344. 10.1146/annurev-pathol-011110-130224, 3628537, 21073340.
    • (2011) Annu Rev Pathol , vol.6 , pp. 323-344
    • Muller, W.A.1
  • 149
    • 33846482153 scopus 로고    scopus 로고
    • Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy
    • Bouzin C, Brouet A, De Vriese J, Dewever J, Feron O. Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J Immunol 2007, 178:1505-1511.
    • (2007) J Immunol , vol.178 , pp. 1505-1511
    • Bouzin, C.1    Brouet, A.2    De Vriese, J.3    Dewever, J.4    Feron, O.5
  • 150
    • 0029943319 scopus 로고    scopus 로고
    • Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium
    • Griffioen AW, Damen CA, Blijham GH, Groenewegen G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 1996, 88:667-673.
    • (1996) Blood , vol.88 , pp. 667-673
    • Griffioen, A.W.1    Damen, C.A.2    Blijham, G.H.3    Groenewegen, G.4
  • 151
    • 0036785604 scopus 로고    scopus 로고
    • B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis
    • Mazanet MM, Hughes CC. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 2002, 169:3581-3588.
    • (2002) J Immunol , vol.169 , pp. 3581-3588
    • Mazanet, M.M.1    Hughes, C.C.2
  • 153
    • 0031594280 scopus 로고    scopus 로고
    • TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation
    • 10.1038/nm0498-415, 2828686, 9546786
    • Sata M, Walsh K. TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med 1998, 4:415-420. 10.1038/nm0498-415, 2828686, 9546786.
    • (1998) Nat Med , vol.4 , pp. 415-420
    • Sata, M.1    Walsh, K.2
  • 154
    • 38549177639 scopus 로고    scopus 로고
    • The puzzling role of TRAIL in endothelial cell biology
    • author reply e5-6
    • Secchiero P, Zauli G. The puzzling role of TRAIL in endothelial cell biology. Arterioscler Thromb Vasc Biol 2008, 28:e4. author reply e5-6.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28
    • Secchiero, P.1    Zauli, G.2
  • 157
    • 0035874949 scopus 로고    scopus 로고
    • Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
    • Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001, 61:4766-4772.
    • (2001) Cancer Res , vol.61 , pp. 4766-4772
    • Woo, E.Y.1    Chu, C.S.2    Goletz, T.J.3    Schlienger, K.4    Yeh, H.5    Coukos, G.6    Rubin, S.C.7    Kaiser, L.R.8    June, C.H.9
  • 159
    • 33847368549 scopus 로고    scopus 로고
    • Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
    • 10.1007/s00262-006-0225-8, 16960692
    • Ghiringhelli F, Menard C, Puig PE, Ladoire S, Roux S, Martin F, Solary E, Le Cesne A, Zitvogel L, Chauffert B. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 2007, 56:641-648. 10.1007/s00262-006-0225-8, 16960692.
    • (2007) Cancer Immunol Immunother , vol.56 , pp. 641-648
    • Ghiringhelli, F.1    Menard, C.2    Puig, P.E.3    Ladoire, S.4    Roux, S.5    Martin, F.6    Solary, E.7    Le Cesne, A.8    Zitvogel, L.9    Chauffert, B.10
  • 160
    • 84863924314 scopus 로고    scopus 로고
    • Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective
    • 10.1158/0008-5472.CAN-11-3912, 22761338
    • Le DT, Jaffee EM. Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective. Cancer Res 2012, 72:3439-3444. 10.1158/0008-5472.CAN-11-3912, 22761338.
    • (2012) Cancer Res , vol.72 , pp. 3439-3444
    • Le, D.T.1    Jaffee, E.M.2
  • 161
    • 80053159303 scopus 로고    scopus 로고
    • The parallel lives of angiogenesis and immunosuppression: cancer and other tales
    • 10.1038/nri3064, 21941296
    • Motz GT, Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol 2011, 11:702-11. 10.1038/nri3064, 21941296.
    • (2011) Nat Rev Immunol , vol.11 , pp. 702-711
    • Motz, G.T.1    Coukos, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.